Characterization and Genetic Analysis of Basal Ganglia Axon Pathfinding

基底节轴突寻路的特征和遗传分析

基本信息

  • 批准号:
    8242817
  • 负责人:
  • 金额:
    $ 18.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-01 至 2013-03-31
  • 项目状态:
    已结题

项目摘要

The development of the basal ganglia and the formation of their connections are complex and poorly understood processes. The basal ganglia are integral to motor function, to cognitive and language development, and to social and emotional regulation. While some genes have been identified with roles in basal ganglia neuron specification, or in diseases of the basal ganglia, how these and other genes regulate the development of basal ganglia connectivity is not known. Further, the actual process of basal ganglia axon pathfinding during development has not been characterized. My hypothesis is that connectivity of the striatum and the mesodiencephalic dopaminergic (mesDA) neurons is controlled by the path- finding gene families of the robos, the s//fs, and the ephslephrins. My long-term objective is to characterize the development and genetic control of basal ganglia connectivity, using zebrafish (Danio rerio) as a model system. In order to explore the development of basal ganglia connections, this project has three specific aims: Aim 1. Develop molecular and genetic markers to visualize striatal and mesodiencephalic dopaminergic (mesDA) neurons and their axons. I am using in situ gene markers and antibodies to label these nuclei. To study their pathfinding, I have generated novel enhancer lines specific for basal ganglia neurons, including dlx(mini):gfp and foxP2-enhancerA:egfp. Aim 2. Characterize the normal axon pathfinding of the zebrafish striatum and mesDA neurons during development. I will use enhancergfp constructs and transgenic lines to describe the development of connectivity, and compare the pathfinding to the expression patterns of the ratios, slits, ephs, and ephrins. Aim 3. Evaluate the role of robo, slit, and ephlephrin genes in striatal and mesDA neuron pathfinding. I will test the function and effects of different members of these gene families by using a combination of mutant fish lines and morpholinos. Clinical Significance: Our results will improve our understanding of the development of basal ganglia connectivity, which is affected in neurodevelopmental and neurodegenerative disorders. Summary: The work described here will be the first description of axon pathfinding of the basal ganglia, characterizing both the development of connectivity and its genetic basis. My results will include both descriptive elements of basal ganglia development, as well as analyses of the role of specific genes. This project consists of a well-structured career development plan, extensively supported with institutional resources and an internationally known mentor, to assist me with the transition during the K award to an independent tenure-track faculty position.
基底神经节的发育及其连接的形成复杂且较差 了解流程。基底神经节是运动功能、认知和语言不可或缺的一部分 发展以及社会和情绪调节。虽然一些基因已被确定在 基底神经节神经元规范,或在基底神经节疾病中,这些基因和其他基因如何调节 基底神经节连接的发展尚不清楚。进一步说,基底神经节的实际过程 发育过程中的轴突寻路尚未得到表征。我的假设是连通性 纹状体和中脑多巴胺能(mesDA)神经元受路径控制 寻找机器人、s//fs 和 ephslephrins 的基因家族。 我的长期目标是表征基底神经节的发育和遗传控制 连接性,使用斑马鱼(Danio rerio)作为模型系统。 为了探索基底神经节连接的发展,该项目有三个具体目标: 目标 1. 开发分子和遗传标记以可视化纹状体和中间脑 多巴胺能(mesDA)神经元及其轴突。我正在使用原位基因标记和抗体来标记 这些原子核。为了研究它们的寻路,我生成了针对基底神经节的新型增强子系 神经元,包括 dlx(mini):gfp 和foxP2-enhancerA:egfp。 目标 2. 表征斑马鱼纹状体和 mesDA 神经元的正常轴突寻路 在开发过程中。我将使用增强gfp构建体和转基因系来描述 连接性,并将寻路与比率、狭缝、ephs 和 ephrins 的表达模式进行比较。 目标 3. 评估 robo、slit 和 ephlephrin 基因在纹状体和 mesDA 神经元寻路中的作用。 我将通过组合使用来测试这些基因家族不同成员的功能和效果 突变鱼系和吗啉。 临床意义:我们的结果将提高我们对基底神经节发育的理解 连接性,在神经发育和神经退行性疾病中受到影响。 摘要:这里描述的工作将是基底神经节轴突寻路的第一个描述, 表征连通性的发展及其遗传基础。我的结果将包括两者 基底神经节发育的描述性要素,以及特定基因作用的分析。 该项目包含一个结构完善的职业发展计划,得到了广泛支持 机构资源和国际知名导师,协助我在 K 期间进行过渡 授予独立终身教授职位。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Josh Leitch Bonkowsky其他文献

Josh Leitch Bonkowsky的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Josh Leitch Bonkowsky', 18)}}的其他基金

Systems for rapid generation of zebrafish mutants and zebrafish embryo handling
快速生成斑马鱼突变体和斑马鱼胚胎处理的系统
  • 批准号:
    9909292
  • 财政年份:
    2020
  • 资助金额:
    $ 18.62万
  • 项目类别:
Development and Validation of a Zebrafish Model for Vanishing White Matter Disease
白质消失病斑马鱼模型的开发和验证
  • 批准号:
    10532469
  • 财政年份:
    2018
  • 资助金额:
    $ 18.62万
  • 项目类别:
The Utah Regional Network for Excellence in Neuroscience Clinical Trials (UR-NEXT)
犹他州神经科学临床试验卓越区域网络 (UR-NEXT)
  • 批准号:
    10744970
  • 财政年份:
    2018
  • 资助金额:
    $ 18.62万
  • 项目类别:
Mechanisms of Serotonergic Regulation for Connectivity Development
连接发展的血清素调节机制
  • 批准号:
    8889940
  • 财政年份:
    2015
  • 资助金额:
    $ 18.62万
  • 项目类别:
Trans-Cellular Activation of Transcription to Analyze Dopaminergic Axon Reorganiz
跨细胞转录激活分析多巴胺能轴突重组
  • 批准号:
    8352193
  • 财政年份:
    2012
  • 资助金额:
    $ 18.62万
  • 项目类别:
The Utah Regional Network for Excellence in Neuroscience Clinical Trials
犹他州神经科学临床试验卓越区域网络
  • 批准号:
    8709000
  • 财政年份:
    2011
  • 资助金额:
    $ 18.62万
  • 项目类别:
Characterization and Genetic Analysis of Basal Ganglia Axon Pathfinding
基底节轴突寻路的特征和遗传分析
  • 批准号:
    8033757
  • 财政年份:
    2008
  • 资助金额:
    $ 18.62万
  • 项目类别:
Characterization and Genetic Analysis of Basal Ganglia Axon Pathfinding
基底节轴突寻路的特征和遗传分析
  • 批准号:
    8618252
  • 财政年份:
    2008
  • 资助金额:
    $ 18.62万
  • 项目类别:
Characterization and Genetic Analysis of Basal Ganglia Axon Pathfinding
基底节轴突寻路的特征和遗传分析
  • 批准号:
    7449190
  • 财政年份:
    2008
  • 资助金额:
    $ 18.62万
  • 项目类别:
Characterization and Genetic Analysis of Basal Ganglia Axon Pathfinding
基底节轴突寻路的特征和遗传分析
  • 批准号:
    7588745
  • 财政年份:
    2008
  • 资助金额:
    $ 18.62万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 18.62万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 18.62万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 18.62万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.62万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了